DeCODE Genetics to unveil gene test for breast cancer risk

Iceland-based deCODE Genetics is set today to launch a test that could help evaluate through a blood sample or cheek swab women's risk for common types of breast cancer. The genetic test could help women "make early diagnoses or take preventive measures," deCODE CEO Kári Stefánsson said. Some cancer experts, however, have expressed concerns about the test, saying the results could lead to a false sense of security or undue alarm.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC